Most recent edit on 2007-11-12 08:48:05 by JasonD [Restored to Original Version by Kathy]
Deletions:
getgetmonac
Edited on 2007-11-11 20:08:49 by RacacElsit
Additions:
getgetmonac
Edited on 2007-05-08 10:13:52 by KathyFromEngland
Additions:
Click here for Prostate Cancer Research Articles:
Prostate Cancer Research May 06 - April 07
Prostate Cancer Research May 07 - April 08
Deletions:
(Click here for Prostate Cancer Research Articles)
Edited on 2007-05-02 00:36:07 by KathyFromEngland
Additions:
A total of 452 men were treated for localized CaP; RRP (197), RPP (60), LRP (137), and CAP (58). Clinical, pathologic and all cost parameters were studied. Costs included surgical, nursing, pharmacy, radiology, laboratory, supplies, etc.
Deletions:
A total of 452 men were treated for localized CaP; RRP (197), RPP (60), LRP (137), and CAP (58). Clinical, pathologic and all cost parameters were studied. Costs included surgical, nursing, pharmacy, radiology, laboratory, supplies, etc.
Oldest known version of this page was edited on 2007-05-02 00:35:22 by KathyFromEngland []
Page view:
Prostate Cancer Treatment News
Includes articles about funding etc.
(
Click here for Prostate Cancer Research Articles)
Contents
* Financial Comparative Analysis Of Minimally Invasive Surgery To Open Surgery For Localized Prostate Cancer: A Single-Institution Experience
* Title 2
* Title 3
Financial Comparative Analysis Of Minimally Invasive Surgery To Open Surgery For Localized Prostate Cancer: A Single-Institution Experience
20 Mar 2007
UroToday.com- In addition to oncologic and quality of life outcomes, cost effectiveness is important to all institutions. Dr. Mouraviev and associates from Duke University report a financial comparison of laparoscopic robotic prostatectomy (LRP), cryoablation of the prostate (CAP), radical retropubic prostatectomy (RRP), and radical perineal prostatectomy (RPP) performed between 2002 and 2005 at their institution. They report decreased costs in the LRP and CAP groups, primarily due to decreased post-operative costs that compensate for increased operative costs.
A total of 452 men were treated for localized
CaP; RRP (197), RPP (60), LRP (137), and CAP (58). Clinical, pathologic and all cost parameters were studied. Costs included surgical, nursing, pharmacy, radiology, laboratory, supplies, etc.
Patients undergoing CAP were significantly older than the other groups and had a median American Society of Anesthesiologists score of 3, compared to a median score of 2 in other groups. The median length of hospital stay was significantly lower (0 days) in the CAP group compared to 3 days in the RRP group, 2 days in the RPP group, and 2 days in the LRP group. The direct median surgical costs were less for RRP ($2,322), and RPP ($2,483) compared to LRP ($3,352) and CAP ($6,153). However, the total hospital cost differences were less for the CAP group ($8,796), and LRP ($9,343) compared to RRP ($9,724) and RPP ($9,251). Part of this is attributable to the fact that there are no associated pathology costs for cryoablation. Two men who underwent CAP met the criteria for PSA recurrence (3.4%) compared to 9.6%, 10.4% and 8.6% in the RRP, RPP, and LRP groups, respectively.
Lower length of hospital stay, transfusions, and laboratory costs account for the cost benefits of minimally invasive procedures.
http://www.medilexicon.com/medicalnews.php?newsid=65627∞
Categories
CategoryCancer